| abstract |
The present application relates to novel substituted triazines of formula (I) in which the ring Q stands for 8- or 9-member heteroaryl and R 4 stands for hydroxy or amino; methods for the production thereof; the use thereof, either alone or in combinations, for the treatment and/or prophylaxis of illnesses; and the use thereof for producing medicinal products for the treatment and/or prophylaxis of illnesses, in particular for the treatment and/or prophylaxis of cardiovascular diseases. |